This Article Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pollock, H. M. Articles by Dahlgren, B. J. Search for Related Content PubMed Articles by Pollock, H. M. Articles by Dahlgren, B. J. Agricola Articles by Pollock, H. M. Articles by Dahlgren, B. J.

 Previous Article  |  Next Article 

Appl Environ Microbiol. 1974 January; 27(1): 141-143
Copyright © 1974 American Society for Microbiology. All Rights Reserved.

Distribution of Streptococcal Groups in Clinical Specimens with Evaluation of Bacitracin Screening

Microbiology Division, Harborview Medical Center, Seattle, Washington 98195
Department of Laboratory Medicine, School of Medicine, University of Washington, Seattle, Washington 98195
Department of Microbiology, School of Medicine, University of Washington, Seattle, Washington 98195

ABSTRACT

During a 2-year period, 4,968 strains of beta-hemolytic streptococci were examined for the clinical source distribution and bacitracin sensitivity of each group. In the upper respiratory tract, groups A (51.7%) and C (20.4%) accounted for most of the isolates, and in wounds and exudates group A (79.1%) made up most of the isolates. Group B (71.2%) was the major component of isolates from the genitorinary tract and, while composing 29.3% of the lower respiratory tract isolates, competed with group A (18.8%) and the nongroupables (22.8%) for supremacy. Bacitracin screening showed that 0.5% of group A streptococci were resistant, and sensitive non-group A isolates were group B (2.6%), group C (6.0%), group G (8.0%), and the nongroupables (2.2%). It was found that those groups which were most predominant in wounds and the upper respiratory tract gave the highest rate of false positives with bacitracin, whereas the predominant group of the genitourinary tract gave the lowest rate of false positives.